Derivatization‐based quadruplex LC/ESI–MS/MS method for high throughput quantification of serum dehydroepiandrosterone sulfate

• Published in: Biomedical chromatography Vol. 35; no. 4; pp. e5027 - n/a
• Main Authors: Aso, Saki, Ogawa, Shoujiro, Nishimoto‐Kusunose, Shoichi, Satoh, Mamoru, Ishige, Takayuki, Nomura, Fumio, Higashi, Tatsuya
• Format: Journal Article
• Language: English
• Published: England 01.04.2021
• Subjects: dehydroepiandrosterone sulfate; derivatization; high throughput; LC/ESI–MS/MS; sample‐multiplexing; sample-multiplexing; dehydroepiandrosterone sulfate; derivatization; high throughput; LC/ESI-MS/MS
• ISSN: 0269-3879; 1099-0801; 1099-0801
• DOI: 10.1002/bmc.5027

The quantification of the circulating dehydroepiandrosterone sulfate (DHEAS) might be of diagnostic help for several diseases. For the DHEAS quantification, LC/ESI–MS/MS has the advantage of a high specificity compared with immunoassay, whereas LC/ESI–MS/MS has room to improve the analysis throughput. One of the promising solutions to enhance the analysis throughput is sample‐multiplexing in the same injection, which can reduce the total LC/ESI–MS/MS run time. In this study, a quadruplex LC/ESI–MS/MS method was developed to quantify DHEAS in four different serum samples in a single run. After the four samples were separately deproteinized and derivatized with one of four Girard reagents (Girard reagent T, P and their isotopologs), the resulting samples were mixed, then injected into the LC/ESI–MS/MS. The applicability and advantage of the developed method were evaluated based on the analysis of nine batches of serum samples from healthy subjects (total 36 samples). The limit of quantitation was 0.050 μg/ml, which was sensitive enough for clinical laboratory use. The method was precise (intra‐ and inter‐assay RSDs ≤ 3.6%), accurate (94.4–108.1%) and robust for the matrix effects. The analysis time was also shortened by about 60% for 36 samples by the introduced method compared with the conventional method.